FDA Approves Melanoma BRAF Companion Test - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

  • By

  • Kathryn Wighton

  • August 10, 2026

  • 1 min

Share

Original Source(s)

FDA Approves Melanoma BRAF Companion Test

  • by Kathryn Wighton

  • August 10, 2026

Related Content

Sunscreen Myths Draw TikTok Engagement

Health-related critiques of sunscreen were uncommon, but videos containing critique drew more audience interaction than promotion-only videos.

What shapes patient attitudes toward TBP skin cancer screening?

Expert consensus highlights communication, privacy, and staff interactions as priorities for a proposed patient-reported experience measure.

FDA Permits New Sunscreen Ingredient After 20 Years

The sunscreen ingredient, which has been marketed internationally for years, is considered generally recognized as safe and effective for use in adults and pediatric patients aged 6 months and older.